Loading…
Loading…
you commented a little bit on this at J.P. Morgan, but just wondering for the five-year strategy, you mentioned the select external innovation as part of the approximate 30% revenue R&D spend. Can ...
comment more on just the inventory demand number for third quarter and how to think about that for fourth quarter
whether there was any bolus effect in cardiomyopathy scripts in second quarter
if there's any perspective you can provide on label discussion progress